Publications by authors named "Sezai Vatansever"

Claim this Profile
R
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study.
Alpaslan Ozgun, Fatma Nihan Akkoc Mustafayev, Izzet Dogan, Sezai Vatansever, Melek Karakurt Eryilmaz

Mol Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Inflammation and Nutrition-Based Scores in Non-Small Cell Lung Cancer.
Mert Erciyestepe, Oğuzhan Selvi, Şermin Dinç Sonuşen, Ahmet Emin Öztürk, Gülhan Dinç, Sezai Vatansever

Med Princ Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Affecting Recurrence and Survival in Stage IIA Colon Cancer Patients.
Mert Erciyestepe, Oğuzhan Selvi, Gülhan Dinç, Ahmet Emin Öztürk, Okan Aydın, Sezai Vatansever

Oncology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rechallenge of Trastuzumab-based Therapy in HER2-Positive Breast Cancer Patients who Progressed Under TDM-1.
Izzet Dogan, Melin Aydan Ahmed, Anıl Yıldız, Sezai Vatansever

Indian J Surg Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients.
Izzet Dogan, Anıl Yıldız, Melin Aydan Ahmed, Sezai Vatansever

Indian J Surg Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer: Excellent Response to 177 Lu-PSMA With No Adrenal Insufficiency.
Edanur Topal, Duygu Has Simsek, Sezai Vatansever, Yasemin Sanli, Serkan Kuyumcu

Clin Nucl Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors: Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST.
Inci Kizildag Yirgin, Izzet Dogan, Gulgun Engin, Sezai Vatansever, Sukru Mehmet Erturk

J Cancer Res Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors.
Izzet Dogan, Nijat Khanmammadov, Anıl Yıldız, Melin Aydan Ahmed, Sezai Vatansever

J Cancer Res Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Significance of Preoperative Computed Tomography Features in the Prediction of Overall Survival in Gastric Cancer: A Retrospective Analysis.
Inci Kizildag Yirgin, Izzet Dogan, Sezai Vatansever, Sukru Mehmet Erturk

Sisli Etfal Hastan Tip Bul· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process.
Izzet Dogan, Inci Kizildag, Selnur Özkurt, Kamuran Ibis, Sezai Vatansever

Oncology· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine.
İzzet Doğan, Nail Paksoy, Naziye Ak, Sezai Vatansever, Pınar Saip

Eur J Breast Health· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases.
Izzet Dogan, Ayca Iribas, Nail Paksoy, Sezai Vatansever, Mert Basaran

J Cancer Res Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study.
Emre Yekedüz, İzzet Dogan, Dılşa Mızrak Kaya, İlker Özgür, Güngör Utkan, Sezai Vatansever

J Gastrointest Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Özlem Özdemir, Baha Zengel, Yaşar Yildiz, Basak Oyan Uluç, Devrim Cabuk, Sezai Vatansever

Anticancer Drugs· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC.
Izzet Dogan, Mustafa Gurbuz, Nail Paksoy, Ferhat Ferhatoglu, Sezai Vatansever

Medicine (Baltimore)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer.
Naziye Ak, Sezai Vatansever

J Clin Pharm Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastases to the Stomach: Clinicopathologic Features of Metastases Mimicking Gastric Primaries.
Ali Yılmaz Altay, Melek Büyük, İlker Özgür, Ali Gök, Bilger Çavuş, Sezai Vatansever

Turk Patoloji Derg· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data.
Mustafa Gürbüz, İzzet Doğan, Erman Akkuş, Hande Ermiş, Güngör Utkan, Sezai Vatansever

Dermatol Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center.
Naziye Ak, Alper Toker, Murat Kara, Berker Özkan, Melike Ülker, Sezai Vatansever

Turk Gogus Kalp Damar Cerrahisi Derg· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Door to Treatment" Outcomes of Cancer Patients during the COVID-19 Pandemic.
Naziye Ak, Sezai Vatansever

Chemotherapy· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are radiologists ready to evaluate true response to immunotherapy?
Inci Kizildag Yirgin, Sukru Mehmet Erturk, Izzet Dogan, Sezai Vatansever

Insights Imaging· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression level of fibulin-2 in the circulating RNA (ctRNA) of epithelial tumor cells of peripheral blood and tumor tissue of patients with metastatic lung cancer.
Mukaddes Avsar, Makbule Tambas, Zubeyde Yalniz, Demet Akdeniz, Seref Bugra Tuncer, Sezai Vatansever

Mol Biol Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical therapy in cancer related vs non-cancer trismus.
Demirhan Dıraçoğlu, Ekin İlke Şen, Sezai Vatansever, Nalan Çapan, Ayşe Karan

Stomatologija· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting progression-free survival in non-HIV-related Kaposi sarcoma.
Fatma Sen, Makbule Tambas, Rumeysa Ciftci, Bahtiyar Toz, Leyla Kilic, Sezai Vatansever

J Dermatolog Treat· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?
Kayhan Erturk, Didem Tastekin, Gokcen Gundogdu, Faruk Tas, Sezai Vatansever

Biomed Pharmacother· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis